How much funding has Ocular Therapeutix raised?

Ocular Therapeutix has raised $836.7M in total funding, most recently a Private Equity round.

When was Ocular Therapeutix founded?

Ocular Therapeutix was founded in 2006.

Where is Ocular Therapeutix headquartered?

Ocular Therapeutix is headquartered in Bedford, Massachusetts, United States.

What industry is Ocular Therapeutix in?

Ocular Therapeutix operates in Biotech, Healthcare.

How many employees does Ocular Therapeutix have?

Ocular Therapeutix has 201-500 employees.

Ocular Therapeutix

Q: Who are Ocular Therapeutix's investors?

Ocular Therapeutix's investors include Public offering, Ascension Health, Polaris Partners.

IPO

Transforming Retinal Disease Treatment with AXPAXLI™

Public · Bedford, United States · Founded 2006 · $836.7M raised

Biotech

Healthcare

Headquarters: Bedford, Massachusetts
Employees: 201–500
Founded: 2006
Business Model: B2B
Website: ocutx.com

Total Funding: $836.7M
Last Round: $475.0M Private EquitySep 2025
Rounds: 8
Type: Public

About

Ocular Therapeutix is a biopharmaceutical company focused on developing and commercializing innovative therapies for diseases of the eye, utilizing its proprietary ELUTYX hydrogel platform to deliver sustained-release drug delivery directly to ocular tissues.

Summary

Ocular Therapeutix is a Biotech company based in Bedford, United States, founded in 2006. It has raised $836.7M in total across 8 rounds, most recently a $475.0M Private Equity round in Sep 2025. Investors include Public offering, Ascension Health and Polaris Partners.

LinkedIn X (Twitter)